/ Ways2Capital : Glenmark Pharma Receives Approval For Clobetasol Propionate Ointment USP 0.05% ~ Ways2Capital|Stock Tips|Stock Market Tips|Intraday Stock Tips|Stock Trading Tips|NSE BSE Tips

Tuesday, 21 March 2017

Glenmark Pharmaceuticals Inc. USA (Glenmark) has been granted final approval by USFDA for Clobetasol Propionate Ointment USP, 0.05%, the generic version of Temovate Ointment, 0.05% of Fougera Pharmaceuticals Inc.

Glenmark’s current portfolio consists of 113 products authorised for distribution in the US marketplace; and approximately 64 ANDAs are pending approval with the US FDA.

Glenmark Pharmaceuticals Limited is a global pharmaceutical company. The Company is engaged in the development of new chemical entities (NCEs) and new biological entities (NBEs).

For Quick Trial – 8962000225 ✔ 
or mail us here: info@ways2capital.com
✆ - 0731-6626222 | Toll Free - 1800-3010-2007
Give a Missed Call for Free Trial - 09699997717